Johns Hopkins Biomedical Engineering: AI-based liquid biopsy may detect liver fibrosis, cirrhosis and chronic disease signals New Johns Hopkins research shows an AI-driven liquid biopsy analyzing genome-wide cfDNA fragment patterns can detect early liver fibrosis & cirrhosis and may signal broader chronic disease burden. AI-based liquid biopsy may detect liver fibrosis, cirrhosis and chronic disease signals Cirrhosis of the liver is a chronic and progressive disease in which healthy liver cells are slowly replaced by scar tissue, severely impairing vital liver functions such as detoxification, hormone ... The etiology of liver cirrhosis has transformed from hepatitis B virus-driven to metabolic dysfunction-associated steatotic liver disease (MASLD).
In this context, researchers have compared the viral ... Seeking Alpha: SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC ... SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC ... STAT: Bariatric surgery halted progression of liver disease in patients with obesity and cirrhosis, study finds Bariatric surgery halted progression of liver disease in patients with obesity and cirrhosis, study finds
